Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study.

Date publication

mars 2024

Journal

Journal of hepatology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe , Pr DI MARTINO Vincent

Tous les auteurs :
Lamarque C, Segaux L, Bachellier P, Buchard B, Chermak F, Conti F, Decaens T, Dharancy S, Di Martino V, Dumortier J, Francoz-Caudron C, Gugenheim J, Hardwigsen J, Muscari F, Radenne S, Salamé E, Uguen T, Ursic-Bedoya J, Antoine C, Deshayes A, Jacquelinet C, Natella PA, Leroy V, Cherqui D, Oubaya N, Duvoux C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38521171

Résumé

To maximize utility and prevent premature liver transplantation (LT), a delayed LT strategy (DS) was adopted in France in 2015 in patients listed for any single HCC treated with resection or thermal-ablation during waiting phase, postponing LT until recurrence. The purpose of this study was to evaluate DS to make sure that it did not hamper pre and post-LT outcomes in DS patients.

Mots clés

delayed strategy, hepatocellularcaninoma, liver resection, liver transplantation, organ allocation, thermal-ablation

Référence

J Hepatol. 2024 03 21;: